327 related articles for article (PubMed ID: 28616743)
1. The long-term survival of stage IV gastric cancer patients with conversion therapy.
Yamaguchi K; Yoshida K; Tanahashi T; Takahashi T; Matsuhashi N; Tanaka Y; Tanabe K; Ohdan H
Gastric Cancer; 2018 Mar; 21(2):315-323. PubMed ID: 28616743
[TBL] [Abstract][Full Text] [Related]
2. [Clinical significance and efficacy of conversion surgery for patients with stage IV gastric cancer].
Zhu Z
Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Oct; 21(10):1087-1092. PubMed ID: 30370504
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of conversion gastrectomy following docetaxel, cisplatin, and S-1 therapy in potentially resectable stage IV gastric cancer.
Kinoshita J; Fushida S; Tsukada T; Oyama K; Okamoto K; Makino I; Nakamura K; Miyashita T; Tajima H; Takamura H; Ninomiya I; Ohta T
Eur J Surg Oncol; 2015 Oct; 41(10):1354-60. PubMed ID: 26028256
[TBL] [Abstract][Full Text] [Related]
4. Surgical Outcome and Long-Term Survival of Conversion Surgery for Advanced Gastric Cancer.
Chen GM; Yuan SQ; Nie RC; Luo TQ; Jiang KM; Liang CC; Li YF; Zhang DY; Yu JH; Hou F; Wang Y; Chen YB
Ann Surg Oncol; 2020 Oct; 27(11):4250-4260. PubMed ID: 32506192
[TBL] [Abstract][Full Text] [Related]
5. Adjuvant Therapy Improves Survival for T2N0 Gastric Cancer Patients with Sub-optimal Lymphadenectomy.
In H; Kantor O; Sharpe SM; Baker MS; Talamonti MS; Posner MC
Ann Surg Oncol; 2016 Jun; 23(6):1956-62. PubMed ID: 26753752
[TBL] [Abstract][Full Text] [Related]
6. Comparison of five tumor regression grading systems for gastric adenocarcinoma after neoadjuvant chemotherapy: a retrospective study of 192 cases from National Cancer Center in China.
Zhu Y; Sun Y; Hu S; Jiang Y; Yue J; Xue X; Yang L; Xue L
BMC Gastroenterol; 2017 Mar; 17(1):41. PubMed ID: 28292272
[TBL] [Abstract][Full Text] [Related]
7. [Progress in conversion therapy for stage IV gastric cancer].
Liang H
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Feb; 24(2):107-111. PubMed ID: 33508914
[TBL] [Abstract][Full Text] [Related]
8. Survival benefit of conversion surgery after intensive chemotherapy for unresectable metastatic gastric cancer: a propensity score-matching analysis.
Ohnuma H; Sato Y; Onoyama N; Hamaguchi K; Hayasaka N; Sato M; Murase K; Takada K; Miyanishi K; Murakami T; Ito T; Nobuoka T; Takemasa I; Kato J
J Cancer Res Clin Oncol; 2021 Aug; 147(8):2385-2396. PubMed ID: 33534051
[TBL] [Abstract][Full Text] [Related]
9. Impact of ypT, ypN, and Adjuvant Therapy on Survival in Gastric Cancer Patients Treated with Perioperative Chemotherapy and Radical Surgery.
Coimbra FJF; de Jesus VHF; Ribeiro HSC; Diniz AL; de Godoy AL; de Farias IC; Felismino T; Mello CAL; Almeida MF; Begnami MDFS; Dias-Neto E; Riechelmann RSP; da Costa WL
Ann Surg Oncol; 2019 Oct; 26(11):3618-3626. PubMed ID: 31222685
[TBL] [Abstract][Full Text] [Related]
10. Prognostic Role of Conversion Surgery for Unresectable Gastric Cancer.
Fukuchi M; Ishiguro T; Ogata K; Suzuki O; Kumagai Y; Ishibashi K; Ishida H; Kuwano H; Mochiki E
Ann Surg Oncol; 2015 Oct; 22(11):3618-24. PubMed ID: 25663597
[TBL] [Abstract][Full Text] [Related]
11. Metastatic adenocarcinomas of the stomach or esophagogastric junction (UICC stage IV) are not always a palliative situation: a retrospective analysis.
Schildberg CW; Weidinger T; Hohenberger W; Wein A; Langheinrich M; Neurath M; Boxberger F
World J Surg; 2014 Feb; 38(2):419-25. PubMed ID: 24146196
[TBL] [Abstract][Full Text] [Related]
12. Significance of histopathological tumor regression after neoadjuvant chemotherapy in gastric adenocarcinomas: a summary of 480 cases.
Becker K; Langer R; Reim D; Novotny A; Meyer zum Buschenfelde C; Engel J; Friess H; Hofler H
Ann Surg; 2011 May; 253(5):934-9. PubMed ID: 21490451
[TBL] [Abstract][Full Text] [Related]
13. A phase II trial of neoadjuvant cisplatin-fluorouracil followed by postoperative intraperitoneal floxuridine-leucovorin in patients with locally advanced gastric cancer.
Brenner B; Shah MA; Karpeh MS; Gonen M; Brennan MF; Coit DG; Klimstra DS; Tang LH; Kelsen DP
Ann Oncol; 2006 Sep; 17(9):1404-11. PubMed ID: 16788003
[TBL] [Abstract][Full Text] [Related]
14. Predictors of Survival in Patients with Resectable Gastric Cancer Treated with Preoperative Chemoradiation Therapy and Gastrectomy.
Badgwell B; Blum M; Estrella J; Chiang YJ; Das P; Matamoros A; Fournier K; Mansfield P; Ajani J
J Am Coll Surg; 2015 Jul; 221(1):83-90. PubMed ID: 26002780
[TBL] [Abstract][Full Text] [Related]
15. Tumor stage after neoadjuvant chemotherapy determines survival after surgery for adenocarcinoma of the esophagus and esophagogastric junction.
Davies AR; Gossage JA; Zylstra J; Mattsson F; Lagergren J; Maisey N; Smyth EC; Cunningham D; Allum WH; Mason RC
J Clin Oncol; 2014 Sep; 32(27):2983-90. PubMed ID: 25071104
[TBL] [Abstract][Full Text] [Related]
16. Treatment of patients with stage IV gastric cancer.
Ikeguchi M; Kader A; Takaya S; Fukumoto Y; Osaki T; Saito H; Tatebe S; Wakatsuki T
J Gastrointest Cancer; 2013 Jun; 44(2):199-202. PubMed ID: 23242564
[TBL] [Abstract][Full Text] [Related]
17. Does graded histologic response after neoadjuvant chemotherapy predict survival for completely resected gastric cancer?
Mansour JC; Tang L; Shah M; Bentrem D; Klimstra DS; Gonen M; Kelsen DP; Brennan MF; Coit DG
Ann Surg Oncol; 2007 Dec; 14(12):3412-8. PubMed ID: 17909917
[TBL] [Abstract][Full Text] [Related]
18. Treatment of stage IV gastric cancer with induction chemotherapy using S-1 and cisplatin followed by curative resection in selected patients.
Saito M; Kiyozaki H; Takata O; Suzuki K; Rikiyama T
World J Surg Oncol; 2014 Dec; 12():406. PubMed ID: 25551581
[TBL] [Abstract][Full Text] [Related]
19. Multidisciplinary treatment for patients with stage IV gastric cancer: the role of conversion surgery following chemotherapy.
Beom SH; Choi YY; Baek SE; Li SX; Lim JS; Son T; Kim HI; Cheong JH; Hyung WJ; Choi SH; Jung M; Kim HS; Jeung HC; Chung HC; Rha SY; Noh SH
BMC Cancer; 2018 Nov; 18(1):1116. PubMed ID: 30442107
[TBL] [Abstract][Full Text] [Related]
20. Proximal Gastric Resection with Posterior Esophago-Gastrostomy and Partial Neo-Fundoplication in the Treatment of Advanced Upper Gastric Carcinoma.
Polkowski WP; Mielko J; Gęca K; Rawicz-Pruszyński K; Ciseł B; Kurylcio A; Skórzewska M
Dig Surg; 2020; 37(2):119-128. PubMed ID: 30909273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
